Data dictionary - Netherlands Cancer Registry (NKR): Difference between revisions

From Beacon
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{forresearchers}}
<span style="display:none">forresearchers</span>
<span style="display:none">thenetherlandscountry</span>
Go back to [[Database: Netherlands Cancer Registry (NKR) (The Netherlands)]] page.
Go back to [[Database: Netherlands Cancer Registry (NKR) (The Netherlands)]] page.


Source: [https://iknl.nl/nkr/registratie/itemsets Click here to learn more].
Source: [https://iknl.nl/nkr/registratie/itemsets Click here to learn more].


There are different types of variables available according to type of tumor and date range. But here we present a general overview of the variables. For more detailed information about the variables available for each type of tumor, visit the data source.
There are different types of variables available according to type of tumour and date range. But here we present a general overview of the variables. For more detailed information about the variables available for each type of tumour, visit the data source.


=== Patient Records ===
=== Patient Records ===
Line 29: Line 30:
|}
|}


=== Tumor Data ===
=== Tumour Data ===
{| class="wikitable"
{| class="wikitable"
! Tumor Data
|-
| Diagnosis date
| Diagnosis date
|-
|-
Line 47: Line 46:
| Pathological TNM stage
| Pathological TNM stage
|-
|-
| Multifocality tumor
| Multifocality tumour
|-
|-
| Pathological size of the tumor (mm)
| Pathological size of the tumour (mm)
|-
|-
| Estrogen receptor status
| Estrogen receptor status
Line 67: Line 66:
| Number of positive regional lymph nodes
| Number of positive regional lymph nodes
|-
|-
| Presence of DCIS component next to invasive tumor
| Presence of DCIS component next to invasive tumour
|-
|-
| BI-RADS classification
| BI-RADS classification
|-
|-
| Tumor palpability
| Tumour palpability
|-
|-
| Breast print rash
| Breast print rash
Line 82: Line 81:
{| class="wikitable"
{| class="wikitable"
|-
|-
! Surgery
| Surgery
|-
|-
! Date of surgery
| Date of surgery
|-
|-
! Surgery discharge date
| Surgery discharge date
|-
|-
! Tumor is an incidental finding during surgery for another indication
| Tumour is an incidental finding during surgery for another indication
|-
|-
! Hospital surgery
| Hospital surgery
|-
|-
! Direct reconstruction
| Direct reconstruction
|-
|-
! Date of immediate reconstruction
| Date of immediate reconstruction
|-
|-
! Direct reconstruction technique
| Direct reconstruction technique
|-
|-
! Hospital direct reconstruction
| Hospital direct reconstruction
|-
|-
! Axillary dissection performed
| Axillary dissection performed
|-
|-
! Date of axillary lymph node dissection
| Date of axillary lymph node dissection
|-
|-
! Hospital axillary dissection
| Hospital axillary dissection
|-
|-
! Basic axillary dissection performed
| Basic axillary dissection performed
|-
|-
! Date of basal axillary lymph node dissection
| Date of basal axillary lymph node dissection
|-
|-
! Hospital of basal axillary dissection
| Hospital of basal axillary dissection
|-
|-
! Radiotherapy
| Radiotherapy
|-
|-
! Start/stop date of radiotherapy
| Start/stop date of radiotherapy
|-
|-
! Type of external radiotherapy
| Type of external radiotherapy
|-
|-
! Hospital radiotherapy
| Hospital radiotherapy
|-
|-
! Systemic chemotherapy
| Systemic chemotherapy
|-
|-
! Start/stop date of systemic chemotherapy
| Start/stop date of systemic chemotherapy
|-
|-
! Hospital systemic chemotherapy
| Hospital systemic chemotherapy
|-
|-
! Systemic hormonal therapy
| Systemic hormonal therapy
|-
|-
! Start date of systemic hormonal therapy
| Start date of systemic hormonal therapy
|-
|-
! Hospital systemic hormonal therapy
| Hospital systemic hormonal therapy
|-
|-
! Systemic target therapy
| Systemic target therapy
|-
|-
! Start-stop date of systemic target therapy
| Start-stop date of systemic target therapy
|-
|-
! Hospital systemic target therapy
| Hospital systemic target therapy
|-
|-
! Active surveillance
| Active surveillance
|-
|-
! Radicality DCIS component surgery
| Radicality DCIS component surgery
|-
|-
! Radicality invasive component surgery
| Radicality invasive component surgery
|-
|-
! No radiotherapy after breast-conserving treatment
| No radiotherapy after breast-conserving treatment
|-
|-
! Reason for no radiotherapy after breast-conserving treatment
| Reason for no radiotherapy after breast-conserving treatment
|-
|-
! Complication during/after surgery
| Complication during/after surgery
|-
|-
! Complication during/after systemic chemotherapy
| Complication during/after systemic chemotherapy
|}
|}


Line 157: Line 156:
{| class="wikitable"
{| class="wikitable"
|-
|-
! Recurrences within 5 years of diagnosis
| Recurrences within 5 years of diagnosis
|-
|-
! Follow-up local recurrence
| Follow-up local recurrence
|-
|-
! Date of follow-up local recurrence
| Date of follow-up local recurrence
|-
|-
! Localization of follow-up local recurrence
| Localization of follow-up local recurrence
|-
|-
! Basis for diagnosis of follow-up local recurrence
| Basis for diagnosis of follow-up local recurrence
|-
|-
! Pathological tumor size (mm) follow-up local recurrence
| Pathological tumour size (mm) follow-up local recurrence
|-
|-
! Follow-up regional recurrence
| Follow-up regional recurrence
|-
|-
! Date of follow-up for regional recurrence
| Date of follow-up for regional recurrence
|-
|-
! Localization of follow-up regional recurrence
| Localization of follow-up regional recurrence
|-
|-
! Basis for diagnosis of follow-up regional recurrence
| Basis for diagnosis of follow-up regional recurrence
|-
|-
! Number of regional lymph nodes examined for follow-up regional recurrence
| Number of regional lymph nodes examined for follow-up regional recurrence
|-
|-
! Number of positive lymph nodes follow-up regionally
| Number of positive lymph nodes follow-up regionally
|-
|-
! Follow-up metastasis
| Follow-up metastasis
|-
|-
! Date of follow-up metastasis
| Date of follow-up metastasis
|-
|-
! Basis for diagnosis follow-up metastasis
| Basis for diagnosis follow-up metastasis
|-
|-
! Topography (incl. sublocalization/lateralization) follow-up metastasis
| Topography (incl. sublocalization/lateralization) follow-up metastasis
|-
|-
! Number of follow-up metastases
| Number of follow-up metastases
|-
|-
! Treatment follow-up
| Treatment follow-up
|-
|-
! Date of last contact follow-up
| Date of last contact follow-up
|-
|-
! Relapses within 10 years of diagnosis
| Relapses within 10 years of diagnosis
|-
|-
! Follow-up local recurrence
| Follow-up local recurrence
|-
|-
! Date of follow-up local recurrence
| Date of follow-up local recurrence
|-
|-
! Follow-up regional recurrence
| Follow-up regional recurrence
|-
|-
! Date of follow-up for regional recurrence
| Date of follow-up for regional recurrence
|-
|-
! Follow-up metastasis
| Follow-up metastasis
|-
|-
! Date of follow-up metastasis
| Date of follow-up metastasis
|-
|-
! Treatment follow-up
| Treatment follow-up
|-
|-
! Relapses due to project
| Relapses due to project
|-
|-
! Follow-up local recurrence
| Follow-up local recurrence
|-
|-
! Localization of local recurrence
| Localization of local recurrence
|-
|-
! Basis for diagnosis of local recurrence
| Basis for diagnosis of local recurrence
|-
|-
! Date of follow-up local recurrence
| Date of follow-up local recurrence
|-
|-
! Pathological tumor size (mm) follow-up local recurrence
| Pathological tumour size (mm) follow-up local recurrence
|-
|-
! Follow-up regional recurrence
| Follow-up regional recurrence
|-
|-
! Localization of regional recurrence
| Localization of regional recurrence
|-
|-
! Basis for diagnosis of regional recurrence
| Basis for diagnosis of regional recurrence
|-
|-
! Date of follow-up for regional recurrence
| Date of follow-up for regional recurrence
|-
|-
! Number of regional lymph nodes examined for follow-up regional recurrence
| Number of regional lymph nodes examined for follow-up regional recurrence
|-
|-
! Number of positive lymph nodes follow-up regional recurrence
| Number of positive lymph nodes follow-up regional recurrence
|-
|-
! Follow-up metastasis
| Follow-up metastasis
|-
|-
! Localization of metastasis
| Localization of metastasis
|-
|-
! Basis for diagnosis of metastasis
| Basis for diagnosis of metastasis
|-
|-
! Date of follow-up metastasis
| Date of follow-up metastasis
|-
|-
! Number of follow-up metastases
| Number of follow-up metastases
|-
|-
! ER, PR, Her2 recurrence or metastasis
| ER, PR, Her2 recurrence or metastasis
|-
|-
! Treatment follow-up
| Treatment follow-up
|}
|}


Line 254: Line 253:
{| class="wikitable"
{| class="wikitable"
|-
|-
! Comorbidity
| Comorbidity
|-
|-
! History of breast surgery
| History of breast surgery
|-
|-
! Smoking status
| Smoking status
|-
|-
! Pregnancy at diagnosis
| Pregnancy at diagnosis
|-
|-
! Performance status
| Performance status
|-
|-
! Weight
| Weight
|-
|-
! Length
| Length
|-
|-
! Incidence year of previous/later malignancies
| Incidence year of previous/later malignancies
|-
|-
! Tumor type previous/later malignancies
| Tumour type previous/later malignancies
|}
|}


Line 277: Line 276:
{| class="wikitable"
{| class="wikitable"
|-
|-
! Tumor detected after referral for population screening
| Tumour detected after referral for population screening
|-
|-
! Reason for diagnosis
| Reason for diagnosis
|-
|-
! Gene mutation research conducted
| Gene mutation research conducted
|-
|-
! Date of gene mutation research
| Date of gene mutation research
|-
|-
! Hospital gene mutation research
| Hospital gene mutation research
|-
|-
! MRI performed
| MRI performed
|-
|-
! MRI date
| MRI date
|-
|-
! Hospital MRI
| Hospital MRI
|-
|-
! Ultrasound-guided puncture and/or biopsy performed in the armpit
| Ultrasound-guided puncture and/or biopsy performed in the armpit
|-
|-
! Date of ultrasound-guided puncture and/or biopsy in the armpit
| Date of ultrasound-guided puncture and/or biopsy in the armpit
|-
|-
! Result of ultrasound-guided puncture and/or biopsy in armpit
| Result of ultrasound-guided puncture and/or biopsy in armpit
|-
|-
! Hospital ultrasound-guided puncture and/or biopsy in the armpit
| Hospital ultrasound-guided puncture and/or biopsy in the armpit
|-
|-
! Post-therapeutic MDO performed
| Post-therapeutic MDO performed
|-
|-
! Date post-therapeutic MDO
| Date post-therapeutic MDO
|-
|-
! Hospital post-therapeutic MDO
| Hospital post-therapeutic MDO
|-
|-
! Pretherapeutic MDO performed
| Pretherapeutic MDO performed
|-
|-
! Date of pre-therapeutic MDO
| Date of pre-therapeutic MDO
|-
|-
! Hospital pretherapeutic MDO
| Hospital pretherapeutic MDO
|-
|-
! Sentinel lymph node procedure performed
| Sentinel lymph node procedure performed
|-
|-
! Date of sentinel procedure
| Date of sentinel procedure
|-
|-
! Result of sentinel procedure
| Result of sentinel procedure
|-
|-
! Hospital sentinel procedure
| Hospital sentinel procedure
|-
|-
! Tumor localization procedure
| Tumour localization procedure
|-
|-
! MARI procedure performed
| MARI procedure performed
|-
|-
! Date of MARI procedure
| Date of MARI procedure
|-
|-
! Result of MARI procedure
| Result of MARI procedure
|-
|-
! Hospital MARI procedure
| Hospital MARI procedure
|-
|-
! Date of first consultation with plastic surgeon for ablation
| Date of first consultation with plastic surgeon for ablation
|-
|-
! Date of first consultation with radiotherapist for pre-surgical therapy
| Date of first consultation with radiotherapist for pre-surgical therapy
|-
|-
! Hospital of first contact regarding malignancy
| Hospital of first contact regarding malignancy
|-
|-
! Date of first consultation in hospital
| Date of first consultation in hospital
|-
|-
! Date of first consultation with practitioner at second hospital
| Date of first consultation with practitioner at second hospital
|-
|-
! Participation in clinical scientific research
| Participation in clinical scientific research
|-
|-
! Operation with plastic surgeon
| Operation with plastic surgeon
|}
|}

Latest revision as of 17:40, 4 December 2025

forresearchers thenetherlandscountry Go back to Database: Netherlands Cancer Registry (NKR) (The Netherlands) page.

Source: Click here to learn more.

There are different types of variables available according to type of tumour and date range. But here we present a general overview of the variables. For more detailed information about the variables available for each type of tumour, visit the data source.

Patient Records[edit | edit source]

Date of birth
Age at diagnosis
Sex
Country of birth
Date of death
Vital status with date
Patient number in the institution
Menopausal status at diagnosis
Postcode figures

Tumour Data[edit | edit source]

Diagnosis date
Basis for diagnosis
Topography (incl. sublocalization/lateralization)
Morphology (incl. behavior/degree of differentiation)
Topography metastasis (incl. sublocalization)
Clinical TNM stage
Pathological TNM stage
Multifocality tumour
Pathological size of the tumour (mm)
Estrogen receptor status
Estrogen receptor value
Progesterone receptor status
Value of progesterone receptor
HER2 status
Technique used for HER2 determination
Number of regional lymph nodes examined
Number of positive regional lymph nodes
Presence of DCIS component next to invasive tumour
BI-RADS classification
Tumour palpability
Breast print rash
Result of oncotype DX

Treatment Details[edit | edit source]

Surgery
Date of surgery
Surgery discharge date
Tumour is an incidental finding during surgery for another indication
Hospital surgery
Direct reconstruction
Date of immediate reconstruction
Direct reconstruction technique
Hospital direct reconstruction
Axillary dissection performed
Date of axillary lymph node dissection
Hospital axillary dissection
Basic axillary dissection performed
Date of basal axillary lymph node dissection
Hospital of basal axillary dissection
Radiotherapy
Start/stop date of radiotherapy
Type of external radiotherapy
Hospital radiotherapy
Systemic chemotherapy
Start/stop date of systemic chemotherapy
Hospital systemic chemotherapy
Systemic hormonal therapy
Start date of systemic hormonal therapy
Hospital systemic hormonal therapy
Systemic target therapy
Start-stop date of systemic target therapy
Hospital systemic target therapy
Active surveillance
Radicality DCIS component surgery
Radicality invasive component surgery
No radiotherapy after breast-conserving treatment
Reason for no radiotherapy after breast-conserving treatment
Complication during/after surgery
Complication during/after systemic chemotherapy

Follow up Data[edit | edit source]

Recurrences within 5 years of diagnosis
Follow-up local recurrence
Date of follow-up local recurrence
Localization of follow-up local recurrence
Basis for diagnosis of follow-up local recurrence
Pathological tumour size (mm) follow-up local recurrence
Follow-up regional recurrence
Date of follow-up for regional recurrence
Localization of follow-up regional recurrence
Basis for diagnosis of follow-up regional recurrence
Number of regional lymph nodes examined for follow-up regional recurrence
Number of positive lymph nodes follow-up regionally
Follow-up metastasis
Date of follow-up metastasis
Basis for diagnosis follow-up metastasis
Topography (incl. sublocalization/lateralization) follow-up metastasis
Number of follow-up metastases
Treatment follow-up
Date of last contact follow-up
Relapses within 10 years of diagnosis
Follow-up local recurrence
Date of follow-up local recurrence
Follow-up regional recurrence
Date of follow-up for regional recurrence
Follow-up metastasis
Date of follow-up metastasis
Treatment follow-up
Relapses due to project
Follow-up local recurrence
Localization of local recurrence
Basis for diagnosis of local recurrence
Date of follow-up local recurrence
Pathological tumour size (mm) follow-up local recurrence
Follow-up regional recurrence
Localization of regional recurrence
Basis for diagnosis of regional recurrence
Date of follow-up for regional recurrence
Number of regional lymph nodes examined for follow-up regional recurrence
Number of positive lymph nodes follow-up regional recurrence
Follow-up metastasis
Localization of metastasis
Basis for diagnosis of metastasis
Date of follow-up metastasis
Number of follow-up metastases
ER, PR, Her2 recurrence or metastasis
Treatment follow-up

Risk Factors[edit | edit source]

Comorbidity
History of breast surgery
Smoking status
Pregnancy at diagnosis
Performance status
Weight
Length
Incidence year of previous/later malignancies
Tumour type previous/later malignancies

Process Data[edit | edit source]

Tumour detected after referral for population screening
Reason for diagnosis
Gene mutation research conducted
Date of gene mutation research
Hospital gene mutation research
MRI performed
MRI date
Hospital MRI
Ultrasound-guided puncture and/or biopsy performed in the armpit
Date of ultrasound-guided puncture and/or biopsy in the armpit
Result of ultrasound-guided puncture and/or biopsy in armpit
Hospital ultrasound-guided puncture and/or biopsy in the armpit
Post-therapeutic MDO performed
Date post-therapeutic MDO
Hospital post-therapeutic MDO
Pretherapeutic MDO performed
Date of pre-therapeutic MDO
Hospital pretherapeutic MDO
Sentinel lymph node procedure performed
Date of sentinel procedure
Result of sentinel procedure
Hospital sentinel procedure
Tumour localization procedure
MARI procedure performed
Date of MARI procedure
Result of MARI procedure
Hospital MARI procedure
Date of first consultation with plastic surgeon for ablation
Date of first consultation with radiotherapist for pre-surgical therapy
Hospital of first contact regarding malignancy
Date of first consultation in hospital
Date of first consultation with practitioner at second hospital
Participation in clinical scientific research
Operation with plastic surgeon
Retrieved from "https://wiki.beaconcancer.org/index.php?title=Data_dictionary_-_Netherlands_Cancer_Registry_(NKR)&oldid=30439"
Powered by MediaWiki
Powered by Semantic MediaWiki